Login to Your Account

BIO 2011

Biomarker Projects Need Broad-Spectrum Collaboration

By Nuala Moran

Thursday, June 30, 2011
WASHINGTON – The biotech industry has long appreciated the value of partnership, but biomarker development is taking collaboration to a new level. It is not possible to develop good and useful biomarkers without involving academics, having access to patients, expertise in sequencing, molecular diagnostics platforms, bioinformatics and the cooperation of clinicians and regulators.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription